CareStars › All contracts › H1969
H1969 · Regence BlueShield of Idaho (REGENCE BLUESHIELD OF IDAHO, INC.): 2027 Star Rating
H1969 (Regence BlueShield of Idaho, REGENCE BLUESHIELD OF IDAHO, INC.) did not get an overall 2027 Star Rating from CMS. Parent company: Cambia Health Solutions, Inc. Plan type: Local CCP.
2027 overall CMS
–
Part C – · Part D 4.5
2026 overall CMS
4.0
Part C 4.0 · Part D 4.0
Change Calc
–
2027 vs 2026
Members Calc
0
CMS county files, October 2026
Open H1969 in CareStars: bonus at stake, measures to fix, local rivalsTalk to Carelytics about H1969
What stands out for H1969
- 5 of its 17 rated measures are at 5 stars; 3 are at 1 or 2 stars. Calc
Weakest high-weight measures
Measures with weight 2 or more and the lowest stars. These move the overall rating most.
- Drug Plan Quality Improvement (D04, weight ×5): 4 stars
- Diabetes Care - Blood Sugar Controlled (C12, weight ×3): 4 stars, score 89
- Controlling High Blood Pressure (C14, weight ×3): 4 stars, score 86
- Medication Adherence for Diabetes Medications (D08, weight ×3): 4 stars, score 91
- Medication Adherence for Hypertension (RAS antagonists) (D09, weight ×3): 5 stars, score 94
All 2027 measure scores Sourced: CMS
| Measure | Weight | Score | Stars |
|---|---|---|---|
| Breast Cancer Screening (C01) | ×1 | 69 | 2 |
| Colorectal Cancer Screening (C02) | ×1 | 78 | 4 |
| Monitoring Physical Activity (C06) | ×1 | 57 | 4 |
| Diabetes Care - Eye Exam (C11) | ×1 | 78 | 3 |
| Diabetes Care - Blood Sugar Controlled (C12) | ×3 | 89 | 4 |
| Kidney Health Evaluation for Patients with Diabetes (C13) | ×1 | 68 | 3 |
| Controlling High Blood Pressure (C14) | ×3 | 86 | 4 |
| Transitions of Care (C19) | ×1 | 82 | 5 |
| Follow-up after Emergency Department Visit for People with Multiple High-Risk Chronic Conditions (C20) | ×1 | 61 | 2 |
| Drug Plan Quality Improvement (D04) | ×5 | – | 4 |
| MPF Price Accuracy (D07) | ×1 | 100 | 5 |
| Medication Adherence for Diabetes Medications (D08) | ×3 | 91 | 4 |
| Medication Adherence for Hypertension (RAS antagonists) (D09) | ×3 | 94 | 5 |
| Medication Adherence for Cholesterol (Statins) (D10) | ×3 | 93 | 5 |
| Statin Use in Persons with Diabetes (SUPD) (D11) | ×1 | 85 | 2 |
| Concurrent Use of Opioids and Benzodiazepines (COB) (D12) | ×1 | 13 | 3 |
| Polypharmacy: Use of Multiple Anticholinergic Medications in Older Adults (Poly-ACH) (D13) | ×1 | 2 | 5 |
Want to move a measure before December 31? Marples, the Carelytics care gap and member engagement platform, ranks the members whose open gaps would move a measure across the next cut point and reaches them by secure text. See how Marples works
Other Cambia Health Solutions, Inc. contracts
H1304 · Regence BlueShield of Idaho · 4.0 starsH1997 · Regence BlueShield · not ratedH3817 · Regence BlueCross BlueShield of Oregon · 3.5 starsH4605 · Regence BlueCross BlueShield of Utah · 4.5 starsH5009 · Regence BlueShield · 4.0 starsH6237 · Regence BlueCross BlueShield of Oregon · 3.5 stars
Sources: CMS 2027 and 2026 Star Ratings data tables (CMS Part C and D performance data); CMS monthly enrollment by contract and county (October 2026). Sourced: CMS marks figures taken from CMS. Calculated marks figures Carelytics added up or compared. Built 2026-10-25.